Literature DB >> 31916888

Translating Pharmacomicrobiomics: Three Actionable Challenges/Prospects in 2020.

Ramy K Aziz1,2, Mariam R Rizkallah3, Rama Saad4, Marwa T ElRakaiby1,2.   

Abstract

Year:  2020        PMID: 31916888     DOI: 10.1089/omi.2019.0205

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


× No keyword cloud information.
  2 in total

Review 1.  The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications.

Authors:  Amir Hossein Miri; Mojtaba Kamankesh; Antoni Llopis-Lorente; Chenguang Liu; Matthias G Wacker; Ismaeil Haririan; Hamid Asadzadeh Aghdaei; Michael R Hamblin; Abbas Yadegar; Mazda Rad-Malekshahi; Mohammad Reza Zali
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

2.  Pharmacological hypothesis: A recombinant probiotic for taming bacterial β-glucuronidase in drug-induced enteropathy.

Authors:  Manon Jardou; Clarisse Brossier; Kenza Guiyedi; Quentin Faucher; Roland Lawson
Journal:  Pharmacol Res Perspect       Date:  2022-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.